Search Results - "Howden, Sara"

Refine Results
  1. 1

    Efficient genome engineering in human pluripotent stem cells using Cas9 from Neisseria meningitidis by Hou, Zhonggang, Zhang, Yan, Propson, Nicholas E., Howden, Sara E., Chu, Li-Fang, Sontheimer, Erik J., Thomson, James A.

    “…Genome engineering in human pluripotent stem cells (hPSCs) holds great promise for biomedical research and regenerative medicine. Recently, an RNA-guided,…”
    Get full text
    Journal Article
  2. 2

    Introducing a Spectrum of Long-Range Genomic Deletions in Human Embryonic Stem Cells Using Type I CRISPR-Cas by Dolan, Adam E., Hou, Zhonggang, Xiao, Yibei, Gramelspacher, Max J., Heo, Jaewon, Howden, Sara E., Freddolino, Peter L., Ke, Ailong, Zhang, Yan

    Published in Molecular cell (06-06-2019)
    “…CRISPR-Cas systems enable microbial adaptive immunity and provide eukaryotic genome editing tools. These tools employ a single effector enzyme of type II or V…”
    Get full text
    Journal Article
  3. 3
  4. 4

    3D organoid-derived human glomeruli for personalised podocyte disease modelling and drug screening by Hale, Lorna J., Howden, Sara E., Phipson, Belinda, Lonsdale, Andrew, Er, Pei X., Ghobrial, Irene, Hosawi, Salman, Wilson, Sean, Lawlor, Kynan T., Khan, Shahnaz, Oshlack, Alicia, Quinlan, Catherine, Lennon, Rachel, Little, Melissa H.

    Published in Nature communications (04-12-2018)
    “…The podocytes within the glomeruli of the kidney maintain the filtration barrier by forming interdigitating foot processes with intervening slit diaphragms,…”
    Get full text
    Journal Article
  5. 5

    Evaluation of variability in human kidney organoids by Phipson, Belinda, Er, Pei X., Combes, Alexander N., Forbes, Thomas A., Howden, Sara E., Zappia, Luke, Yen, Hsan-Jan, Lawlor, Kynan T., Hale, Lorna J., Sun, Jane, Wolvetang, Ernst, Takasato, Minoru, Oshlack, Alicia, Little, Melissa H.

    Published in Nature methods (01-01-2019)
    “…The utility of human pluripotent stem cell–derived kidney organoids relies implicitly on the robustness and transferability of the protocol. Here we analyze…”
    Get full text
    Journal Article
  6. 6
  7. 7
  8. 8

    Plasticity of distal nephron epithelia from human kidney organoids enables the induction of ureteric tip and stalk by Howden, Sara E., Wilson, Sean B., Groenewegen, Ella, Starks, Lakshi, Forbes, Thomas A., Tan, Ker Sin, Vanslambrouck, Jessica M., Holloway, Emily M., Chen, Yi-Hsien, Jain, Sanjay, Spence, Jason R., Little, Melissa H.

    Published in Cell stem cell (01-04-2021)
    “…During development, distinct progenitors contribute to the nephrons versus the ureteric epithelium of the kidney. Indeed, previous human pluripotent…”
    Get full text
    Journal Article
  9. 9
  10. 10
  11. 11

    Forward steps in organoid-based forward screening by Little, Melissa H., Howden, Sara E.

    Published in Cell stem cell (06-01-2022)
    “…In this issue of Cell Stem Cell, Ungricht et al. (2022) perform a temporally controlled CRISPR/Cas9-based genome-wide screen in kidney organoids to uncover key…”
    Get full text
    Journal Article
  12. 12

    A Cas9 Variant for Efficient Generation of Indel-Free Knockin or Gene-Corrected Human Pluripotent Stem Cells by Howden, Sara E., McColl, Bradley, Glaser, Astrid, Vadolas, Jim, Petrou, Steven, Little, Melissa H., Elefanty, Andrew G., Stanley, Edouard G.

    Published in Stem cell reports (13-09-2016)
    “…While Cas9 nucleases permit rapid and efficient generation of gene-edited cell lines, the CRISPR-Cas9 system can introduce undesirable “on-target” mutations…”
    Get full text
    Journal Article
  13. 13

    Chemically defined conditions for human iPSC derivation and culture by Chen, Guokai, Gulbranson, Daniel R, Hou, Zhonggang, Bolin, Jennifer M, Ruotti, Victor, Probasco, Mitchell D, Smuga-Otto, Kimberly, Howden, Sara E, Diol, Nicole R, Propson, Nicholas E, Wagner, Ryan, Lee, Garrett O, Antosiewicz-Bourget, Jessica, Teng, Joyce M C, Thomson, James A

    Published in Nature methods (01-05-2011)
    “…A defined and simplified culture system for the derivation and growth of human induced pluripotent stem cells is reported. It permits increased efficiency of…”
    Get full text
    Journal Article
  14. 14
  15. 15
  16. 16

    Reporter‐based fate mapping in human kidney organoids confirms nephron lineage relationships and reveals synchronous nephron formation by Howden, Sara E, Vanslambrouck, Jessica M, Wilson, Sean B, Tan, Ker Sin, Little, Melissa H

    Published in EMBO reports (01-04-2019)
    “…Nephron formation continues throughout kidney morphogenesis in both mice and humans. Lineage tracing studies in mice identified a self‐renewing Six2‐expressing…”
    Get full text
    Journal Article
  17. 17

    Simultaneous Reprogramming and Gene Correction of Patient Fibroblasts by Howden, Sara E., Maufort, John P., Duffin, Bret M., Elefanty, Andrew G., Stanley, Edouard G., Thomson, James A.

    Published in Stem cell reports (08-12-2015)
    “…The derivation of genetically modified induced pluripotent stem (iPS) cells typically involves multiple steps, requiring lengthy cell culture periods, drug…”
    Get full text
    Journal Article
  18. 18

    Functional Assessment of Patient-Derived Retinal Pigment Epithelial Cells Edited by CRISPR/Cas9 by Foltz, Leah P, Howden, Sara E, Thomson, James A, Clegg, Dennis O

    “…Retinitis pigmentosa is the most common form of inherited blindness and can be caused by a multitude of different genetic mutations that lead to similar…”
    Get full text
    Journal Article
  19. 19

    Generating Kidney from Stem Cells by Little, Melissa H, Hale, Lorna J, Howden, Sara E, Kumar, Santhosh V

    Published in Annual review of physiology (10-02-2019)
    “…Human kidney tissue can now be generated via the directed differentiation of human pluripotent stem cells. This advance is anticipated to facilitate the…”
    Get full text
    Journal Article
  20. 20

    Generating Kidney Organoids from Human Pluripotent Stem Cells Using Defined Conditions by Howden, Sara E, Little, Melissa H

    “…The ultimate goal of regenerative medicine is to have access to an unlimited supply of specific cell types on demand, which can be used as effective therapies…”
    Get more information
    Journal Article